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Abstract 44 
To combat the high burden of rotavirus gastroenteritis, multiple African countries 45 
have introduced rotavirus vaccines into their childhood immunisation programmes.  46 
Malawi incorporated a G1P[8] rotavirus vaccine (Rotarix™) into its immunisation 47 
schedule in 2012. Utilising a surveillance platform of hospitalised rotavirus 48 
gastroenteritis cases, we examined the phylodynamics of G1P[8] rotavirus strains 49 
that circulated in Malawi before (1998 – 2012) and after (2013 – 2014) vaccine 50 
introduction. Analysis of whole genomes obtained through next generation 51 
sequencing revealed that all randomly-selected pre-vaccine G1P[8] strains 52 
sequenced (n=32) possessed a Wa-like genetic constellation, whereas post-vaccine 53 
G1P[8] strains (n=18) had a DS-1-like constellation. Phylodynamic analyses 54 
indicated that post-vaccine G1P[8] strains emerged through reassortment events 55 
between human Wa- and DS-1-like rotaviruses that circulated in Malawi from the 56 
1990’s, hence classified as atypical DS-1-like reassortants. The time to the most 57 
recent common ancestor for G1P[8] strains was from 1981-1994; their evolutionary 58 
rates ranged from 9.7 x 10-4–4.1 x 10-3 nucleotide/substitutions/site/year. Three 59 
distinct G1P[8] lineages chronologically replaced each other between 1998 and 60 
2014. Genetic drift was the likely driver for lineage turnover in 2005, whereas 61 
replacement in 2013 was due to reassortment. Amino acid substitution within the 62 
outer glycoprotein VP7 of G1P[8] strains had no impact on the structural 63 
conformation of the antigenic regions, suggesting that it is unlikely that they would 64 
affect recognition by vaccine-induced neutralizing antibodies. While the emergence 65 
of DS-1-like G1P[8] rotavirus reassortants in Malawi was therefore likely due to 66 
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natural genotype variation, vaccine effectiveness against such strains needs careful 67 
evaluation.  68 
 69 
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Importance 87 
The error-prone RNA-dependent RNA polymerase and the segmented RNA genome 88 
predispose rotaviruses to genetic mutation and genome reassortment, respectively. 89 
These evolutionary mechanisms generate novel strains and have the potential to 90 
lead to the emergence of vaccine-escape mutants. While multiple African countries 91 
have introduced rotavirus vaccine, there are few data describing the evolution of 92 
rotaviruses that circulated before and after vaccine introduction. We report the 93 
emergence of atypical DS-1-like G1P[8] strains during the post-vaccine era in 94 
Malawi. Three distinct G1P[8] lineages circulated chronologically from 1998–2014; 95 
mutation and reassortment drove lineage turnover in 2005 and 2013, respectively. 96 
Amino acid substitutions within the outer capsid VP7 glycoprotein did not affect the 97 
structural conformation of mapped antigenic sites, suggesting limited effect in 98 
recognition of G1 specific vaccine-derived antibodies. The genes that constitute the 99 
remaining genetic backbone may play important roles in immune evasion, and 100 
vaccine effectiveness against such atypical strains needs careful evaluation. 101 
 102 
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Introduction 110 
Diarrhoea is a leading cause of mortality in children under the age of five 111 
years globally (1, 2). The majority of hospitalisations and deaths in infants due to 112 
severe dehydrating diarrhoea are caused by group A rotaviruses (RVA) (3). The 113 
World Health Organization (WHO) recommended universal introduction of 114 
rotavirus vaccines in 2009 particularly in countries where diarrhoea mortality is 115 
high (4). A global decline from 528,000 to 215,000 in rotavirus-associated deaths 116 
per year amongst children <5 years of age has been reported between 2000 and 117 
2013, and live-attenuated oral rotavirus vaccines (Rotarix™; RV1 and RotaTeq®; 118 
RV5) have now been incorporated into national immunization programs of over 60 119 
countries worldwide (5). 120 
RVA are members of the Reoviridae virus family. They are enveloped 121 
icosahedric viruses that contain a triple-layered capsid encasing 11 genome 122 
segments of double-stranded RNA (dsRNA). The rotavirus genome encodes six 123 
structural (VP1 – VP4, VP6 and VP7) and five to six non-structural proteins (NSP1 – 124 
NSP5/NSP6) (6). Nucleotide homology cut-off values of the open reading frame 125 
(ORF) for each genome segment are used to classify rotavirus strains on the basis of 126 
the whole genome composition (7, 8). To date, 35 G (VP7), 50 P (VP4), 26 I (VP6), 21 127 
R (VP1), 19 C (VP2), 19 M (VP3), 30 A (NSP1), 20 N (NSP2), 21 T (NSP3), 26 E 128 
(NSP4), and 21 H (NSP5) genotypes have been described (8-12). 129 
(http://rega.kuleuven.be/cev/viralmetagenomics/virus-classification). 130 
G1 – G4, G9 and G12 in association with P[4], P[6] or P[8] are the 131 
predominant  genotypes associated with human rotavirus infection worldwide (6, 132 
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13-15). Although several G and P genotype combinations have been detected among 133 
human rotaviruses, the genotypes for the other nine genes are limited to 134 
predominantly genotype 1 (I1-R1-C1-M1-A1-N1-T1-E1-H1; Wa-like) and genotype 2 135 
(I2-R2-C2-M2-A2-N2-T2-E2-H2; DS-1-like) (16). For instance, typically RVAs 136 
G1P[8], G3P[8], G4P[8], G9P[8] and G12P[8] have a Wa-like genotype constellation, 137 
whereas G2P[4] and G8P[4] or G8P[6] strains usually possess a DS-1-like 138 
constellation (16-18). The segmented RNA genome of rotaviruses and their error 139 
prone RNA-dependent RNA polymerase, which lacks proof-reading activity (6), 140 
allows various evolutionary mechanisms including genetic mutation, recombination 141 
and reassortment. This leads to the emergence of distinct lineages within individual 142 
genotypes, or reassortant viruses containing segments from different progenitor 143 
strains (6, 19, 20).  144 
Novel double-reassortant DS-1-like G1P[8] rotaviruses have recently 145 
emerged in southeast Asia. These atypical G1 strains were initially detected in 146 
outbreaks of gastroenteritis among Japanese children (21-23), followed by reports 147 
from Thailand (24, 25) and then Vietnam (26). To date, there is no evidence that 148 
these atypical G1 strains are widespread. Rotavirus strain surveillance conducted in 149 
Blantyre, Malawi since 1997, and introduction of the monovalent, Wa-like G1P[8] 150 
rotavirus vaccine (Rotarix™ or RV1) into Malawi’s childhood immunisation 151 
programme in 2012, allows study of the evolution of G1P[8] strains  before and after 152 
vaccine introduction. We have, for the first time detected DS-1-like G1P[8] rotavirus 153 
strains in Africa, which became predominant following vaccine introduction. The 154 
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evolutionary forces that were associated with the emergence of the atypical G1P[8] 155 
rotavirus strains were also determined.  156 
 157 
Results 158 
Emergence of reassortant DS-1-like G1P[8] rotavirus strains  159 
All pre- (33.4%: 1,634/4,888) and post-vaccine (22.6%: 477/2,109) rotavirus–160 
positive stools collected from children presenting with acute severe diarrhoea at 161 
QECH were genotyped as part of on-going rotavirus surveillance (27-30). Amongst 162 
multiple strains were characterised, and G1P[8] rotaviruses were consistently 163 
predominant strains that were detected each year before (39.4%: 554/1406) and 164 
after (31.4%: 95/303) vaccine introduction (Fig. 1a and S1). Whole genome 165 
sequences of 32 pre-vaccine G1P[8] strains (collected between  1998 and 2012), 166 
and 18 post-vaccine G1P[8] strains (collected from 2013 to 2014)  were successfully 167 
generated (see supplementary Table 1 for yearly distribution). Interruption of 168 
surveillance in 2010 meant that no G1P[8] strains were available between 2010 and 169 
2011. Among the pre-vaccine G1P[8] strains, 31 had the  G1-P[8]-I1-R1-C1-M1-A1-170 
N1-T1-E1-H1 genotype constellation, hence designated as Wa-like G1P[8], whereas 171 
one was G1-P[8]-I1-R1-C1-M1-A1-N1-T2-E1-H1, hence designated as a mono-172 
reassortant Wa-like G1P[8] strain. In contrast, 16/18 of the post-vaccine G1P[8] 173 
strains had  a DS-1-like genotype constellation (G1-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-174 
H2) hence were designated as atypical double-reassortant DS-1-like G1P[8] strains. 175 
The remaining two post-vaccine G1P[8] strains (BID1LN and BID230) had Wa-like 176 
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VP1 (R1) and Wa-like NSP3 (T1) genes, respectively, hence were designated as 177 
atypical triple-reassortant DS-1-like G1P[8] strains (Fig. 1b and Table S1).  178 
 179 
Atypical post-vaccine G1P[8] strains emerged through genome reassortment 180 
between Wa-like and DS-1-like human rotaviruses  181 
Whilst the concatenated sequences of all 11 genome segments of pre- and 182 
post-vaccine G1P[8] rotaviruses clustered with prototype Wa- and DS-1-like strains, 183 
respectively (Fig. 1b), phylogenetic networks constructed using concatenated whole 184 
genome sequences of G1P[8] strains characterised in the revealed frequent 185 
reassortment events between strains from the same or different network clusters 186 
(Fig. 1c). The Malawi G1P[8] strains were distributed into three main phylogenetic 187 
network clusters (L1, L2 and L3), which also contained multiple sub-clusters 188 
(shaded within main clusters in Fig. 1c). L1 phylogenetic cluster contained strains 189 
that circulated from 1998 to 2004; strains detected from 2005 to 2012 grouped into 190 
L2 cluster, while L3 cluster only consisted of post-vaccine G1P[8] strains that 191 
circulated from 2013 to at least 2014 in Blantyre.  192 
The phylogenetic relationship of Malawi G1P[8] strains was inferred using 193 
the Maximum-Likelihood method for which complete nucleotide sequences of RVAs 194 
available in the GenBank and sequences of Wa-like (VP4 and VP7 only) and DS-1-195 
like (the other nine genes) strains from Malawi were used. The DS-1-like genes of 196 
the post-vaccine G1P[8] reassortants closely clustered with those of G2 strains that 197 
circulated simultaneously in Malawi (Fig. S2) and not with DS-1-like G1P8] strains 198 
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identified in Southeast Asia and Japan. Sequences within each cluster were 95 – 199 
99.8% similar (calculated using nucleotide identity matrices, data not shown).  200 
All eleven genome segments of the G1P[8] strains were undergoing purifying 201 
selection thus potentially resulting in stabilizing selection following purging of 202 
deleterious variants arising during error-prone rotavirus replication due to its RNA 203 
genome (Table 1). The genetic algorithm for recombination detection (GARD) (31) 204 
and the single breakpoint recombination (SBP) (32) did not identify any 205 
recombination events within each genome segment of the study strains (Table 1). 206 
Thus, the change in genetic constellation of post-vaccine G1P[8] strains were likely 207 
generated through exchange of whole gene segment (reassortment) between 208 
circulating Wa-like and DS-1-like human rotaviruses.  209 
 210 
G1P[8] strains that circulated in Malawi between 1998 and 2014 exhibited 211 
distinct replacement dynamic patterns 212 
Bayesian inference of time-measured trees were individually constructed for 213 
each of the 11 genome segments of the G1P[8] strains to further determine their 214 
evolutionary dynamics. As illustrated by phylogenetic networks, prior to the 215 
emergence of the reassortant L3 lineage, both structural and non-structural genes 216 
segregated into at least 2 distinct lineages with a common ancestor in the mid 217 
1990’s or before (Fig. 2 and S3). For NSP1, NSP2, NSP3, VP1, VP2, VP3 and VP6, a 218 
single lineage (L1) was predominant until the mid-2000’s (2003-2005), and 219 
following its disappearance, strains forming a second lineage L2 circulated until the 220 
emergence of the DS-1-like G1P[8] reassortant strains. For the VP4, VP7 and NSP4 221 
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genes, two clusters co-circulated until 2004, and replacement with strains in L2 did 222 
not occur until later, between 2010 and 2012.  In 2013, VP7 and VP4 encoding genes 223 
of the emergent reassortant strains also formed a third cluster with likely common 224 
ancestor with strains in L2. Both MCC coalescent framework and Maximum-225 
Likelihood phylogenetic approaches showed that G1P[8] strains acquired DS-1-like 226 
genome segments (genotype 2) in the nine non-VP4 and non-VP7 genes in 2013, 227 
out-competing typical Wa-like L2 variants (genotype 1) during the post-vaccine era 228 
(Fig. 2 and S2-S4). These analyses also showed that the post-2013 Malawi DS-1-like 229 
G1P[8] reassortant strains clustered with or were derived from Wa-like G1P[8] 230 
strains and DS-1-like G2 strains that co-circulated in Malawi, and hence emerged 231 
through reassortment among local strains. The genes of Malawi DS-1-like G1P[8] 232 
strains clustered away from those of DS-1-like reassortants that emerged recently in 233 
southeast Asian countries and Japan indicating that they were likely not imported.  234 
Since the post-vaccine Malawi G1P[8] strains contained a DS-1-like genetic 235 
backbone, only sequences for the Wa-like genome segments for G1P[8] strains 236 
generated in this study were used for phylodynamic analysis of VP4 and VP7 genes, 237 
whereas cognate genes of DS-1-like strains that were assigned various G and P types 238 
(Table S1), which also circulated in Malawi from 1997 – 2014 were used to estimate 239 
evolutionary dynamics for non-VP4 and non-VP7 genes for post-vaccine G1P[8] 240 
strains (Fig. 3 and S4). The calculated mean times per gene to the most recent 241 
common ancestor (tMRCA) ranged from 1986 to 1996 (Fig. 4a). When only non-VP4 242 
and non-VP7 genes (NSP1 – NSP4, VP1 – VP3 and VP6) for reassortant DS-1-like 243 
G1P[8] and cognate genes of DS-1-like strains collected from Malawi between 1997 244 
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and 2014 were used to infer Bayesian time-measured trees, the tMRCA for the 245 
atypical G1P[8] strains (L3 cluster) was estimated to range from 2009 – 2011 which 246 
was similar to predominantly DS-1-like G2 strains that were detected post-vaccine 247 
introduction (Fig 3. and Fig. S4). Marginal differences were observed between the 248 
mean evolutionary rates for each genome segment that ranged from 9.7 x 10-4  – 4.1 249 
x 10-3 nucleotide substitutions per site per year (Fig. 4b). VP2 had the lowest 250 
mutation rates (9.7 x 10-4; 95% Highest Posterior Density interval (HPD): 7.4 x 10-4 251 
to 1.2 x 10-3 substitutions per site per year), whereas VP3 had the highest (4.1 x 10-3 252 
HPD; 3.1 x 10-3 to 5 x 10-3 (Fig. 4b Fig. 3 and Fig. S4).   253 
We then utilized GMRF tree prior to investigate whether Rotarix™ 254 
introduction had an impact on the relative population size of the circulating G1P[8] 255 
strain. There was no evidence to suggest that vaccine introduction affected either 256 
the G1P[8] genetic diversity nor population size for VP4, VP7, NSP2, NSP3 and NSP5 257 
genes as the peaks and troughs of their Skygrid plots exhibited similar stable 258 
profiles just before (2005 – 2012) and after (2013 – 2014) vaccine use. In contrast, 259 
genes encoding VP1 – VP3, VP6 and NSP1 had relatively stable profiles and also 260 
smaller effective population size during the post-vaccine era compared to pre-261 
vaccine introduction which could be natural as similar downward trends were 262 
already occurring before vaccine introduction (Fig. 4c).  263 
 264 
Mutations within VP7 antigenic regions did not affect the structural 265 
conformation of neutralising epitopes essential for antigenic recognition by 266 
neutralising antibodies 267 
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Mapped amino acid motifs that constitute neutralising epitopes on the outer 268 
capsid glycoprotein were compared between Rotarix™ and Malawian G1P[8] 269 
strains. In total, 15 lineage defining amino acid substitutions were identified across 270 
the entire VP7 sequence, with only five of these being located at the mapped 271 
antigenic regions 7-1a (S123N and K291R) and 7-2 (AR C: M202T, M212T and 272 
N221S) (Fig. 5a).  A single amino acid substitution N221S located at one of these 273 
antigenic regions differentiated L3 from the L2 cluster strains (Fig. 5).  274 
The VP7 structures for L1 – L3 strains and Rotarix™ strain aligned perfectly 275 
when superimposed (Fig. 5b) implying a conserved conformation consistent with 276 
the conservation in chemical properties of the replacing amino acids. The replacing 277 
amino acids did not appear to impact on the structural conformation of the antigenic 278 
regions of the glycocapsid protein of the G1P[8] circulating pre and post vaccine 279 
introduction (Fig. 5c – e).  280 
 281 
Discussion 282 
Malawi was one of the first African countries to introduce rotavirus vaccine 283 
into its infant immunization schedule in October 2012. By 2015, vaccine coverage 284 
had exceeded 95% (30). We enhanced rotavirus surveillance activities in the post-285 
vaccine period in Malawi to primarily assess the impact of vaccine introduction on 286 
the burden of rotavirus disease (27, 30). The availability of a rotavirus strain 287 
collection from before (1997 – 2012) (28) and after Rotarix™  introduction offered a 288 
rare opportunity to assess the early impact of  vaccine introduction on the genetic 289 
diversity of the circulating strains and their evolutionary patterns over time. In the 290 
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current study, phylogenetic analysis and evolutionary history were inferred for 291 
G1P[8] rotaviruses, the most prevalent rotavirus strain globally (6). In Malawi, 292 
G1P[8] strains were the only rotaviruses consistently detected year on year, from 293 
1998 to  2014 hence enabling  a systematic inference of evolutionary patterns over 294 
time. Furthermore, G1P[8] strains are homologous with respect to VP7 and VP4 295 
genotype to the Rotarix™ vaccine that is in use in Malawi (33), hence permitting 296 
homologous genomic comparison.  297 
Whilst the pre-vaccine G1P[8] strains had a typical Wa-like genetic 298 
constellation (8, 16, 34, 35), the backbone of the G1P[8] strains detected after 299 
vaccine introduction possessed a DS-1-like genotype constellation, which is most 300 
frequently associated with G2P[4] strains,  occasionally with G9 and G12 strains, 301 
and with G8P[4] or G8P[6] strains in Africa (8, 17, 18, 36). Detection of atypical 302 
reassortant DS-1-like G1P[8] strains had not been documented during  15 years of 303 
pre-vaccine rotavirus strain surveillance in Malawi or elsewhere in  Africa. Similar 304 
atypical reassortant DS-1-like G1P[8] strains emerged recently in Southeast Asian 305 
countries where rotavirus vaccine use is limited (21-26). Atypical DS-1-like G1P[8] 306 
strains from Malawi and Asia exhibited distinct phylogenetic clustering patterns in 307 
all 11 genome segments, indicating that these atypical DS-1-like G1P[8] strains most 308 
likely emerged independently in Malawi and Asia and did not arise through 309 
importation. In addition:  (i) tight clustering between G and P genes of the atypical 310 
Malawian G1P[8] strains with other G1P[8] Wa-like strains, (ii) monophyletic 311 
clusters between non-G and non-P genes of Malawian atypical G1P[8] strains with 312 
other Malawian DS-1-like strains, and (iii) evidence of frequent reassortment events 313 
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among DS-1- and Wa-like  strains circulating in Malawi during the study period 314 
revealed by phylogenetic networks, together suggest that the atypical Malawian 315 
G1P[8] strains emerged locally through genome reassortment among co-circulating 316 
Wa- and DS-1-like strains. This is further supported by the detection of high 317 
prevalence of G2 strains reported in Malawi from 2012 (27, 30), thus providing the 318 
required circulating strains to allow the emergence of Wa/DS-1-like reassortant 319 
strains.  320 
The Malawian G1 mutation rate falls in the same range as those of rotavirus 321 
G9 and G12 strains (37-41). Zeller et al. (35) recently analysed the phylodynamics of 322 
typical Wa-like G1P[8] strains that circulated before and after vaccine introduction 323 
in Belgium and Australia. Unlike the Malawian G1P[8] strains, all G1P[8] strains 324 
from Belgium and Australia had a Wa-like genetic constellation and their tMRCA 325 
ranged from 1846 – 1945, whereas their evolutionary rates which ranged from 6.05 326 
x 10-4  – 1.01 x 10-3 nucleotide substitutions per site per year were similar to those 327 
for Malawian G1P[8] strains. These are relatively slower compared to the known 328 
rates of RNA viruses (42) possibly due to the double stranded nature of rotavirus 329 
genome.  330 
The emergence of the atypical reassortant DS-1-like G1P[8] strains in Malawi 331 
coincided with the programmatic roll-out of Rotarix™. Our data suggest that the 332 
atypical Malawian DS-1-like G1P[8] derived from a combination of reassortment 333 
and drift of rotaviruses that were circulating locally since the  1990’s. We found that 334 
at least three G1P[8] lineages have been circulating in Malawi from 1998 – 2014. 335 
The diversity of the circulating G1P[8] variants exhibited periodic lineage 336 
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replacements,  similar to influenza (43), dengue (44) and other enteric viruses such 337 
as noroviruses (45), where lineage replacement also appears to be an important 338 
evolutionary mechanism in response to herd immunity (35, 46, 47). Lineage 339 
diversity and replacement coincided temporally for blocks of genes, and can be 340 
explained by drift and reassortment events occurring hand in hand.  341 
Although the detection of DS-1-like G1P[8] strains coincided with 342 
widespread use of a G1P[8] Rotarix™ rotavirus vaccine in Malawi in 2013, it is 343 
difficult to ascertain the role the vaccine had on the emergence of these atypical 344 
strains considering the short post-vaccine period. The phylodynamic analyses 345 
suggested that these strains were derived from those strains circulating in the 346 
human population well before vaccine introduction. It was difficult to determine the 347 
effect of vaccine introduction on the effective population size of the circulating 348 
G1P[8] strains as only post-vaccine G1 strains from 2013 and 2014 were analysed, 349 
which was too early to detect genetic variations in the virus population size. 350 
Frequent detection of DS-1-like G2 strains just before Rotarix™ introduction and 351 
during the post-vaccine era in Malawi (27, 30) may indicate a natural surge of DS-1-352 
like rotaviruses during this period similar to G2 cyclic seasonal epidemic patterns 353 
that has been observed in many countries including in Africa (48, 49). However, the 354 
predominance of reassortant DS-1-like G1P[8] strains post-vaccine introduction 355 
could suggest positive selection for atypical G1P[8] strains, and that such selection 356 
may not be driven exclusively by the VP7 and VP4 specificities. The DS-1-like 357 
genotype constellation was however found in rotavirus diarrhoea cases regardless 358 
of the vaccination status of the children (48% were vaccinated, data not shown). 359 
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The relatively fewer rotavirus G1P[8] genomes that were analysed is a potential 360 
limitation of the current study as such sequencing of additional G1P[8] strains that 361 
circulated in Malawi post-2014 is underway to determine whether emergence of 362 
DS-1-like G1P[8] strains remain in circulation. 363 
It has been shown that mutations along the three main mapped neutralising 364 
epitopes of VP7 can generate vaccine-escape mutants (50). For instance, amino acid 365 
substitutions at positions 94, 97, 147 and 291 significantly affect antigenic 366 
recognition of human G1 strains (50). When VP7 of post-vaccine G1P[8] strains (L3) 367 
were compared to that of Rotarix™, only K291R (7-1a) substitution occurred within 368 
the sites associated with antibody escape mutants, and this substitution was already 369 
present among the strains circulating pre-vaccine introduction since 1998, hence 370 
not selected due to potential vaccine pressure. Furthermore, both Lysine (K) and 371 
Arginine (R) are positively charged polar proteins hence this substitution is unlikely 372 
to produce significant changes to the biochemical properties of VP7. The only 373 
substitution present among the post-vaccine G1 strains was N221S. As both 374 
asparagine (N) and serine (S) are small non-charged residues, it does not appear to 375 
have a significant impact on the overall conformation and structure of the protein 376 
surface. However, the loss of an asparagine residue may have resulted in the loss of 377 
a potential glycosylation site which could affect VP7 antigenic determinants (51). 378 
This change does not appear to be a universal glycosylation position as Serine also 379 
occurs naturally at position 221 for some non-G1 strains like S2 (G2), RV-5 (G3) and 380 
ST5 (G4) (52). Whilst this change is outside of the currently proven glycosylation 381 
sites (69 – 71, 238 – 240 and 318 – 320), the N221S change occurred within the 382 
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neutralizing epitope C (Antigenic regions C) of VP7 (52). In order to exclude the 383 
potential for this amino acid substitution, further functional studies may be 384 
warranted bearing in mind that changes in immunogenicity and neutralisation 385 
patterns have been attributed to different glycosylation patterns using mutated 386 
laboratory strains (51, 53). 387 
The only hydrophobic to hydrophilic change, which would potentially affect the 388 
structural conformation and stability of proteins significantly, occurred outside the 389 
mapped antigenic regions at position 266 [Alanine (A) to S], and was also present 390 
among the strains circulating pre 2009, those in L2. However, it is possible that 391 
substitutions in the non-AR could affect the stability of the viral particle or protein 392 
assortment specificities, since VP6 serves as an anchor for the outer capsid VP4 and 393 
VP7 proteins where the 260 trimers of VP7 lie directly on top of the VP6 trimers 394 
(54). Contact with VP6 is facilitated by the arm-like extensions formed by the VP7 N-395 
termini that also forms lattice with other VP7 trimers. This interaction allows 396 
gripping of VP7 to the intermediate VP6 layer and reinforces the integrity of the 397 
outer-shell (55). Such interactions may drive the selection of particular VP7 and/or 398 
VP4 lineages in reassortant strains and explain lineage replacements that may not 399 
necessarily be explained exclusively in terms of immune pressure. In a recent 400 
analysis, vaccine effectiveness against all G1P[8] strains three years post-Rotarix™ 401 
introduction in Malawi was 82% (30), suggesting high degree of protection  against 402 
atypical DS-1-like G1P[8] strains, given that these G1P[8] strains were detected in 403 
randomly selected stool samples collected between  2013 – 2014. Further analysis is 404 
underway in order to assess the extent of the spread of the DS-1-like G1P[8] strains 405 
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and to calculate vaccine effectiveness against various G and P types possessing Wa- 406 
and DS-1-like genetic backbone.  407 
In conclusion, genome reassortment and mutation are the major 408 
evolutionary mechanism that influenced the genetic diversity of G1P[8] strains that 409 
circulated in Malawi from 1998 – 2014. Atypical DS-1-like G1P[8] strains emerged 410 
in 2013 through genome reassortment events between Wa- and DS-1-like human 411 
strains that can be traced back  in Malawi to  the  1990’s. Mutations within the outer 412 
capsid VP7 of Malawian G1P[8] strains compared to RV1 had no impact on the 413 
structural conformation of antigenic regions, suggesting little or no effect on the 414 
recognition of vaccine-induced antibodies. Thus, the remaining genome segments 415 
(non-G or -P) might also play an important role in immune evasion. It is likely that 416 
the atypical DS-1-like G1P[8] strains emerged through natural strain evolutionary 417 
pressure which is unrelated to vaccine use. However, the predominance of atypical 418 
reassortant DS-1-like G1P[8] strains, which coincided with vaccine introduction, 419 
could suggest positive selection of atypical G1P[8] strains that were undergoing 420 
purifying selection. Vaccine effectiveness against such atypical strains needs careful 421 
investigation. 422 
 423 
Materials and methods 424 
Rotavirus strains   425 
Stool samples collected from children aged <5 years presenting with acute 426 
gastroenteritis at Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi from 427 
1998 – 2014 were utilised (27-29). Diarrhoea-case definition, rotavirus screening, 428 
 o
n
 January 10, 2018 by University of Liverpool Library
http://jvi.asm.org/
D
ow
nloaded from
 
 20 
VP4 and VP7 genotyping methods and strains that circulated in Malawi have been 429 
published elsewhere (27-29). In total, 4,888 stool specimens were collected before 430 
vaccine introduction (1997 – 2012), whereas 2,109 were collected after vaccine 431 
introduction (2013 – 2014). Rotaviruses with G1P[8] outer capsid proteins were the 432 
only strains that were detected every year from 1998 – 2015 (comprising of 554 433 
pre- and 95 post-vaccine introduction strains). Therefore, only G1P[8] strains from 434 
each surveillance year, and that had sufficient faecal material for dsRNA re-435 
extraction were selected for further examination. Where available, a single faecal 436 
sample from each month in each year was randomly selected for whole genome 437 
sequencing; only samples from which whole genome data were obtained were 438 
included in the analysis. Ethical approval was obtained from the National Health 439 
Sciences Research Committee, Lilongwe, Malawi (# 867) and the Research Ethics 440 
Committee of the University of Liverpool, Liverpool, UK (# 000490).  441 
 442 
Preparation of purified dsRNA and cDNA for rotavirus whole genome 443 
Rotavirus dsRNA was extracted and purified as previously described (17, 444 
56). An additional DNase I treatment step following a lithium chloride precipitation 445 
step was included to remove contaminating DNA (Sigma-Aldrich, Dorset, UK). 446 
Purified dsRNA was quantified using a Qubit® 3.0 Fluorometer (Life Technologies, 447 
CA, USA). Sequence-independent cDNA synthesis and PCR amplification procedures 448 
described previously (17, 56) were used to amplify cDNA for rotavirus whole 449 
genomes from samples with > 2ng/µl dsRNA. 450 
 451 
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RNA and cDNA library construction and illumina HiSeq sequencing 452 
After denaturing dsRNA at 95oC for 5 min, ScriptSeq RNA-Seq Library 453 
Preparation Kit V2 was used to generate Illumina sequencing libraries for samples 454 
that had <2 ng/µl dsRNA (Illumina Inc., CA, USA). Purified cDNA generated from 455 
samples with >2 ng/µl dsRNA was subjected to standard bar-coding and library 456 
construction for illumina sequencing using Nextera XT DNA Library Preparation Kit 457 
(Illumina Inc., CA, USA). Rotavirus VP6-specific qPCR (57) and 2100 Bioanalyzer 458 
(Agilent Technologies Inc., CA, USA) were used to quality control the DNA libraries 459 
followed by sequencing using HiSeq 2000 platform (Illumina Inc., CA, USA) at the 460 
Centre for Genomic Research (CGR), University of Liverpool, UK. 461 
 462 
Sequence assembly and determination of rotavirus genotypes 463 
Illumina adapter sequences were trimmed from the raw Fastq sequence data 464 
using Cutadapt v1.2.1 (58) and Sickle v1.2 software (59). Complete consensus 465 
nucleotide sequences were generated by mapping trimmed illumina sequence reads 466 
to various complete nucleotide sequences of prototype rotavirus genogroup strains 467 
using both de novo and Reference DNA sequence assembler algorithms 468 
implemented in Geneious software v8 (60). Rotavirus genotypes were assigned to 469 
each of the 11 genome segments using the web-based automated rotavirus 470 
genotyping tool, RotaC v2.0 (http://rotac.regatools.be) (7). All complete nucleotide 471 
and deduced amino acid sequences generated in this study were deposited into the 472 
GenBank (61) under the accession numbers MG181227 - MG181941. 473 
 474 
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Sequence alignments and Maximum Likelihood phylogeny construction 475 
Reference nucleotide sequences for each rotavirus genome segment were 476 
retrieved from the Rotavirus resource in the GenBank database (61). This was 477 
followed by multiple sequence alignment of the assembled sequences for the study 478 
strains using Muscle v3.8.31 (62) included in MEGA, v6.0 (63). Initial phylogenetic 479 
trees for each segment were inferred using Maximum Likelihood approach 480 
implemented in MEGA by selecting the DNA model that best fitted the data 481 
according to the corrected Akaike Information Criterion (AICc) as described 482 
previously (12). We used a generalized time reversible (GTR) model with Gamma 483 
(Υ) heterogeneity across nucleotide sites while the reliability of the branching order 484 
and partitioning were assessed by performing 1000 bootstrap replicates (64).  485 
 486 
Bayesian inference of phylogenies and population dynamics 487 
Coalescent analyses were performed using BEAUTi v1.7.5 and BEAST v1.8 488 
(65, 66) with the following parameter specifications; lognormal relaxed 489 
(uncorrelated) clock model (67), constant size coalescent tree prior, Hasegawa-490 
Kishino-Yano (HKY85) nucleotide substitution model with estimated base 491 
frequencies (68) and a Gamma (Υ) site heterogeneity model with 4 rate categories 492 
(69) and the prior mutation rate () of ~1.0 x 10-3 nucleotide 493 
substitutions/site/year as previously reported by Zeller et al (35). The maximum 494 
likelihood trees generated in the previous section were used as starting trees for the 495 
Bayesian analysis in BEAST. We used a Gaussian Markov Random Field (GMRF) tree 496 
prior, which also allows for investigation of the population dynamics i.e. effective 497 
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population size (Neτ) or relative genetic diversity, over time. A total of 200 million 498 
Markov Chain Monte Carlo (MCMC) iterations were performed and sampled every 499 
40,000th generation. The first 20 million iterations (10% of the total) from the 500 
MCMC analysis, burn-in time, were discarded since these may represent states that 501 
the chain explored before reaching the equilibrium state of the target distribution. 502 
The mean values and 95% highest posterior densities (HPD) of the mutation rates 503 
and the times to the most recent common ancestors (tMRCA) for each rotavirus 504 
segment were calculated from the BEAST output using Tracer v1.6.0 505 
(http://tree.bio.ed.ac.uk/software/tracer/). The maximum clade credibility (MCC) 506 
tree for each viral segment was generated using Tree Annotator v2.1.2 507 
(http://beast.bio.ed.ac.uk/treeannotator) and visualized using FigTree v1.4.2 508 
(http://tree.bio.ed.ac.uk/software/figtree/) and BioPython scripts (70).  509 
Detection of natural selection in proteins encoded by rotavirus segments 510 
ORFs that encode both the structural and non-structural proteins were 511 
identified and extracted from the multiple sequence alignments of each rotavirus 512 
genomic segment. We used BioPython (70) scripts to extract and manipulate the 513 
sequence alignments. The ORFs alignments for each protein were then converted to 514 
corresponding codon alignments using CodonAlign (http://www.hiv.lanl.gov/cgi-515 
bin/CodonAlign). The alignments were then used to calculate the global ratio of 516 
synonymous and non-synonymous substitutions (dN/dS) for each ORF using single 517 
likelihood ancestor counting (SLAC) (71) and a Fast, Unconstrained Bayesian 518 
AppRoximation for Inferring Selection (FUBAR)(72). To identify specific sites under 519 
selection in the ORFs, we also used the mixed effects model of episodic selection 520 
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(MEME)(73), random effects likelihood (REL) (74) and fixed effects likelihood (FEL) 521 
(75) methods implemented in DataMonkey, a webserver for the HyPhy package 522 
(76). Occurrence of genetic recombination was checked using the genetic algorithm 523 
for recombination detection (GARD) (31) and the single breakpoint recombination 524 
(SBP) (32). We used the following default significance levels i.e. p-value, Bayes 525 
Factor or posterior probability of 0.1 for SLAC, MEME and FEL, 0.9 for FUBAR and 526 
50 for REL. The Hasegawa-Kishino-Yano 85 (HKY85) nucleotide substitution model, 527 
Beta-Gamma site-to-site rate variation and Neighbour-Joining trees were used for 528 
the selection analysis. All the analyses were done using the DataMonkey webserver 529 
(71). 530 
 531 
Structure comparison between the outer capsid glycoprotein of RV1 and  532 
G1P[8] strains to predict changes in antibody binding 533 
To investigate the likely impact of amino acid substitutions on anti-RV1 534 
antibody recognition due to mutations that occurred over time within the antigenic 535 
regions of Malawian G1P[8] rotaviruses, the structural conformation of the outer 536 
capsid glycoprotein of pre- and post-vaccine strains were compared to that of RV1. 537 
Representative VP7 sequences for each G1P[8] lineage were utilised for protein 538 
structure modeling using Modeler Version 9.17 (77). Templates were searched in 539 
Protein Data bank (78) using an integrated web based HHpred program (79). The 540 
best model with highest zdope score was selected for analysis from the one hundred 541 
models that were generated for each sequence. 542 
 543 
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Figure Legends 858 
Fig. 1. Rotavirus strains, genetic constellation and phylogenetic networks of 859 
G1P[8] rotaviruses detected from Malawian children at QECH from 1997 – 860 
2015. (a) Schematic representation of the proportions of all genotypes detected in 861 
rotavirus-positive stool samples. The size of the circle is directly proportion to the 862 
detection frequency of G and P genotypes. There were no rotavirus 863 
surveillance activities in 2010 hence samples were not collected. (b) Bayesian 864 
Maximum Clade Credibility tree for concatenated whole rotaviruses genome 865 
sequences illustrating genetic constellation and reassortment patterns for 32 pre- 866 
and 18 post-vaccine G1P[8] strains from Malawi as well as the prototype Wa and 867 
DS-1 strains for comparison. Genotype and genogroups assignment for each 868 
segment were based on nucleotide sequence identities, assigned using RotaC. 869 
Genome segment that were assigned the same genotype are shown with the same 870 
colour and genotype numbers. Green represents Wa-like P[8] for VP4 and genotypes 871 
1 for the rest of the other 10 gene segments; Red represents all DS-1-like genotype 2 872 
for all 11 gene segments. (C) Phylogenetic network of complete concatenated whole 873 
genome sequences of G1P[8] rotavirus strains detected in Malawi from 1998 – 874 
2014. Branches are drawn to scale and splits in the network indicate reassortments. 875 
Network clusters are colour-coded and named in accordance with their phylogenic 876 
lineages (L1 – L3) that correlated with time of strain isolation before or after 877 
rotavirus vaccine introduction. Cluster L1 (green) and L2 (blue) contained pre-878 
vaccine G1P[8] strains, whereas L3 (red) contained post-vaccine strains. Network 879 
sub-clusters within each main cluster are shaded in blue (L1), red (L2) or orange 880 
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(L3).  881 
Fig. 2. Bayesian Maximum Clade Credibility (MCC) time tree based on 882 
complete nucleotide sequences illustrating lineage replacement within the 883 
genome segments encoding structural proteins of the G1P[8] strains that 884 
circulated in Malawi from 1998 – 2014. With the exception of VP4 and VP7 genes 885 
that had L2 and L3 genes sharing close ancestry, the rest had three distinct G1P[8] 886 
lineages. L1, L2, and L3 represents lineage 1, 2 and 3, respectively.  887 
 888 
Fig. 3. Bayesian Maximum Clade Credibility (MCC) time tree based on 889 
complete nucleotide sequences of the structural proteins for G1P[8] strains 890 
from Malawi. Only DS-1-like genome segments for typical DS-1-like strains that 891 
were assigned G2P[4], G2P[6], G8P[4], G8P[6] and G12P[6] outer capsid genotypes 892 
from Malawi were included to calculate evolutionary dynamics for VP1 – VP4, VP6 893 
and VP7 encoding genome segments for the atypical DS-1-like G1P[8] strains (L3 894 
cluster). The summary for their evolutionary rates and tMRCA are presented in 895 
Table 2.  896 
 897 
Fig. 4. Time to the most recent common ancestor (TMRCA), evolutionary rates 898 
for each genome segment of Malawian G1P[8] strains and comparative 899 
population dynamics of G1P[8] rotavirus strains circulating in Malawi, 1998 – 900 
2014. (a) The evolutionary rates and tMRCAs for each genome segment of the 901 
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Malawian atypical G1P[8] strains shown together with their 95% Highest Posterior 902 
Density (HPD) intervals. (b) Absolute values for the mean and range of the 903 
evolutionary rates and tMRCA at 95% HPD intervals are shown. (c) Phylogenies 904 
and relative genetic diversity were estimated using the Gaussian Markov Random 905 
Field (GMRF) model represents Bayesian Skygrid plots for VP1 – VP4, VP6, for NSP1 906 
– NSP5 encoding genome segments. Solid lines in the GMRF plot represent the mean 907 
relative genetic diversity through time.  908 
 909 
Fig. 5. Amino acid substitutions and structural conformation of the outer 910 
capsid glycoprotein of Malawian G1P[8] strains. (a) Complete VP7 sequence of 911 
representative pre- and post-vaccine G1P[8] strains aligned to that of RV1 912 
exhibiting amino acid substitutions that occurred within the variable regions (VR) 913 
and mapped antigenic regions (AR) over time. Lineage defining amino acid amino 914 
acid substitutions are highlighted in green, blue and yellow for L1, L2 and L3 915 
lineages, respectively. Pre- and post-vaccine strains are shown with vertical green 916 
and red bars on the right, respectively. Strains belonging to the L1, L2 and L3 917 
phylogenetic clusters are shown with green, blue and red bars respectively on the 918 
right. (b) Perfect alignment of superimposed VP7 structures exhibiting few 919 
differences between RV1 and L1 – L3 strains. Antigenic regions A, B and C are 920 
shown in white. L1 – L3 and RV1 strains are shown in yellow, green, blue and red, 921 
respectively. (c - e) Surface visualisation of VP7 from the outside of the virion on 3-922 
fold axis displaying amino acid differences when structures for L1 (c), L2 (d) and L3 923 
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(e) G1P[8] strains were superimposed on the outer capsid glycoprotein of RV1. 924 
Numbers correspond to the positions where mutations occurred.  925 
 926 
 927 
 928 
 929 
 930 
 931 
 932 
 933 
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Table 1. Evolutionary selective forces and recombination in all eleven proteins 
of the Malawian G1P[8] rotavirus strains. 
Protein SLAC FUBAR
a Consensus Selective 
Force 
Recombination 
dN/dS ω (β/α) GARD SBP 
VP1 0.0502 2.22 Purifying Selection - - 
VP2 0.0538 2.67 Purifying Selection - - 
VP3 0.0965 2.47 Purifying Selection - - 
VP4 0.1052 3.15 Purifying Selection - - 
VP6 0.0310 4.66 Purifying Selection - - 
VP7 0.2033 6.01 Purifying Selection - - 
NSP1 0.2239 4.21 Purifying Selection - - 
NSP2 0.0920 5.62 Purifying Selection - - 
NSP3 0.0870 5.44 Purifying Selection - - 
NSP4 0.1097 7.10 Purifying Selection - - 
NSP5 0.1097 7.47 Purifying Selection - - 
 
aThis summary table reports the means of posterior distribution of synonymous (α) and 
non-synonymous (β) substitution rates over sites, as well as the mean posterior 
probability for ω (=β/α) < 1 at a site. 
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